CLDX

CELLDEX THERAPEUTICS INC

CLDX·15117B202·US·Common Stock·Healthcare - Biotechnology-13D/G

CLDX (CELLDEX THERAPEUTICS INC) is held by 128 institutional investors as of Q2 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($355.1M), BlackRock, Inc. ($260.6M), PRICE T ROWE ASSOCIATES INC /MD/ ($174.3M). Net institutional sentiment: Bullish.

128
Holders
(11 Elite)
$2.1B
Total Value
71% (124)
Consensus
88 buying - 36 selling
13F: Insider & Congress: Updated regularly
CLDX

Smart Money Verdict

View all
Loading verdict
Held by 128 funds
11 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Jun 18, 2024 · Activists Oct 7, 2026 · Congress none

ActivistFMR LLCFMR LLC10.7%Oct 7, 2026
ActivistKYKynam Capital Management, LP6.8%Aug 14, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.6.0%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
9.5M(+11.5%)$355.1M0.1%-10.43%
35
Increased
7M(+30.4%)$260.6M0.0%+5.13%
39
Increased
4.7M(+124.6%)$174.3M0.0%-19.83%
49
Increased
3.9M(+39.1%)$145.1M0.0%-4.29%
40
Decreased
3.7M(-0.7%)$138.5M0.0%-33.25%
0
Increased
3.5M(+17.0%)$128.9M0.0%-9.50%
35
Increased
2M(+19.8%)$75.3M0.0%-9.98%
35
Increased
1.6M(+63.4%)$60.1M0.0%-11.91%
43
Increased
1.2M(+77.7%)$44M0.2%-7.36%
53
Decreased
1.2M(-6.6%)$43.6M0.0%+18.17%
0
Increased
1.1M(+1.4%)$40M0.0%+5.19%
29
Increased
1M(+21.7%)$38.8M0.0%-6.80%
35
New
989,442$36.8M0.2%-20.91%
48
Decreased
985,677(-2.8%)$36.7M0.0%+10.09%
0
Decreased
917,408(-0.7%)$34.1M0.0%+8.45%
0
Increased
863,536(+37.2%)$32.1M0.0%-11.38%
38
Increased
788,696(+438.3%)$29.3M0.0%-19.81%
46
Increased
719,647(+24.7%)$26.8M0.0%-12.62%
35
Increased
700,830(+40.1%)$26.1M0.1%-6.82%
38
Increased
661,235(+382.6%)$24.6M0.0%-14.93%
46

Showing 1-20 of 136

1 / 7
CLDXCLDXCELLDEX THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used